Consolidated Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Consolidated Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.61M	Sell	7,200 -3,965	-36%	-$1.9M	0.31%	55
2026 Q1	$5.49M	Buy	11,165 +435	+4%	+$236K	0.6%	35
2025 Q4	$6.22M	Sell	10,730 -3,000	-22%	-$1.7M	0.74%	28
2025 Q3	$6.66M	Hold	13,730	–	–	0.82%	26
2025 Q2	$5.57M	Hold	13,730	–	–	0.75%	30
2025 Q1	$6.83M	Sell	13,730 -570	-4%	-$309K	1.05%	22
2024 Q4	$7.44M	Hold	14,300	–	–	1.04%	20
2024 Q3	$8.85M	Hold	14,300	–	–	1.31%	17
2024 Q2	$7.91M	Hold	14,300	–	–	1.23%	19
2024 Q1	$8.31M	Hold	14,300	–	–	1.34%	19
2023 Q4	$7.59M	Hold	14,300	–	–	1.34%	20
2023 Q3	$7.24M	Hold	14,300	–	–	1.4%	17
2023 Q2	$7.46M	Hold	14,300	–	–	1.34%	16
2023 Q1	$8.24M	Sell	14,300 -800	-5%	-$451K	1.61%	15
2022 Q4	$8.31M	Hold	15,100	–	–	1.78%	9
2022 Q3	$7.66M	Hold	15,100	–	–	1.66%	15
2022 Q2	$8.2M	Hold	15,100	–	–	1.56%	14
2022 Q1	$8.92M	Hold	15,100	–	–	1.45%	16
2021 Q4	$10.1M	Hold	15,100	–	–	1.6%	15
2021 Q3	$8.63M	Hold	15,100	–	–	1.35%	16
2021 Q2	$7.62M	Buy	15,100 +2,600	+21%	+$1.23M	1.27%	20
2021 Q1	$5.71M	Hold	12,500	–	–	1.25%	22
2020 Q4	$5.82M	Hold	12,500	–	–	1.52%	17
2020 Q3	$5.52M	Hold	12,500	–	–	1.86%	15
2020 Q2	$4.53M	Sell	12,500 -4,500	-26%	-$1.51M	1.71%	17
2020 Q1	$4.82M	Hold	17,000	–	–	2.13%	15
2019 Q4	$5.52M	Hold	17,000	–	–	2.6%	15
2019 Q3	$4.95M	Sell	17,000 -5,815	-25%	-$1.67M	2.55%	15
2019 Q2	$6.7M	Sell	22,815 -5,000	-18%	-$1.38M	3.51%	9
2019 Q1	$7.61M	Hold	27,815	–	–	3.8%	7
2018 Q4	$6.22M	Hold	27,815	–	–	3.18%	7
2018 Q3	$6.79M	Hold	27,815	–	–	3.17%	9
2018 Q2	$5.76M	Buy	27,815 +2,800	+11%	+$594K	2.79%	11
2018 Q1	$5.17M	Hold	25,015	–	–	2.5%	13
2017 Q4	$4.75M	Hold	25,015	–	–	2.45%	15
2017 Q3	$4.73M	Hold	25,015	–	–	2.39%	15
2017 Q2	$4.36M	Buy	25,015 +1,500	+6%	+$252K	2.32%	16
2017 Q1	$3.61M	Hold	23,515	–	–	2.06%	17
2016 Q4	$3.32M	Hold	23,515	–	–	2.08%	18
2016 Q3	$3.74M	Hold	23,515	–	–	2.29%	12
2016 Q2	$3.48M	Hold	23,515	–	–	1.76%	17
2016 Q1	$3.33M	Hold	23,515	–	–	1.54%	24
2015 Q4	$3.33M	Hold	23,515	–	–	1.5%	22
2015 Q3	$2.88M	Buy	23,515 +2,031	+9%	+$265K	1.33%	27
2015 Q2	$2.79M	Hold	21,484	–	–	1.32%	27
2015 Q1	$2.89M	Buy	21,484 +8,638	+67%	+$1.11M	1.38%	29
2014 Q4	$1.61M	Buy	12,846 +5,131	+67%	+$624K	0.8%	40
2014 Q3	$939K	Buy	+7,715	New	+$938K	0.46%	52

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Consolidated Investment Group's TMO Position: Q2 2026 in Review

Consolidated Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 36% in Q2 2026, selling an estimated $1.9M and leaving 7,200 shares worth $3.61M. The position accounts for 0.31% of the portfolio, ranked #55.

Consolidated Investment Group first reported a position in TMO in Q3 2014 and has held it in 48 quarters since. The position peaked at $10.1M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Consolidated Investment Group held 7,200 shares of Thermo Fisher Scientific worth $3.61M as of Q2 2026.
Consolidated Investment Group sold 3,965 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.9M.
Thermo Fisher Scientific made up 0.31% of Consolidated Investment Group's portfolio in Q2 2026, its #55 holding.
Consolidated Investment Group first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 48 quarters since.
Consolidated Investment Group's Thermo Fisher Scientific position peaked at $10.1M in Q4 2021.
794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Consolidated Investment Group's 13F filing for Q2 2026, filed 22 Jul 2026.